Suominen’s Q4 revenue topped expectations, but profitability didn’t reach estimates.
VEF continued the strong 30%+ NAVPS CAGR seen over the past six years, while its share price appears...
CapMan reported Q4 EBIT of 12.2m, 8% above Infront consensus and 52% above Nordea estimates.
CapMan's net sales in Q4 amounted to EUR 14.7m (EUR 14.
According to Finnish prime minister, Finland is aiming to ease restaurant restrictions on 14 Februar...
DT’s Q4 result fell slightly short of our estimates.
Analysguiden inleder bevakning av forskningsbolaget Stayble Therapeutics.
CapMan is set to finish a year of solid performance.
1.1 million infants die annually, where 80% suffer from Respiratory Distress Syndrome (RDS).
Stark avslutning på året BE Group levererade ett underliggande rörelseresultat på 135 mkr i Q4'21 (1...
Unik marknadsledande position Candles Scandinavia (Candles) är unika med att erbjuda högkvalitativa ...
Analysguiden inleder bevakning av dryckeskoncernen Umida Group med riktkurs 11 kronor.
Relesys A/S (”Relesys or the ”Company”) develops and licenses an all-in-one platform, gathering dail...
On Friday, 28 January, BankNordik lifted its 2021 net profit guidance to DKK 270m (previously DKK 23...
Nyemission möjliggör förvärv Under november kommunicerade bolaget att man avsåg genomföra en riktad ...
Stabil finansiell situation Diamyd presenterade under onsdagen sin Q1-rapport för det brutna räkensk...
AAC Clyde Space continues to make progress, although supplier issues constrained Q321.
God tillväxt Physitrack redovisade en omsättning om 2,4m EUR (0,9m) under Q4'21, vilket motsvarar en...
NoHo will report its Q4 figures on 17 February. The company was forced to lower its 2021 guidance on...
Q4 sales were 9% below our forecast, largely reflecting lower growth in Performance Chemical than we...
